New drug to 'significantly improve' breast cancer treatment

The Irish Clinical Oncology Research Group has claimed that the introduction of a new chemotherapy drug will significantly improve breast cancer treatment in Ireland.

The Irish Clinical Oncology Research Group has claimed that the introduction of a new chemotherapy drug will significantly improve breast cancer treatment in Ireland.

The group said international studies had indicated that women treated with the drug had a significantly lower rate of relapse than patients undergoing standard chemotherapy.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

Lunchtime News

Newsletter

Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited